[ET Net News Agency, 27 March 2024] SKB BIO-B (06990) fell 9.8% to HK$144.8, dipping
below the 10-D SMA of HK$156.23.
It hits an intra-day low of HK$144.5, and an intra-day high of HK$160. The total shares
traded was 237,800, with a value of HK$36.21m. The active buy/sell ratio is 52:48, with
net buying turnover of HK$1.26m. CHINA INNOVATION MARKET SER accounts for greatest net
responsive buying turnover of HK$5.55m, with volume weighted average price of HK$155.575.
MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of HK$2.72m,
with volume weighted average price of HK$149.248. The stock has fallen a combined 15.6%
over the past 2 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 144.800 % Chg -9.84%
High 160.000 Low 144.500
Shares Tr 237,800 Turnover 36.21m
10-D SMA 156.230 %H.V 94.460
20-D SMA 136.605 VWAP 152.278
50-D SMA 109.550 RSI14 56.993
-----------------------------------
Status: Dipping below the 10-D SMA, active buy/sell ratio is 52:48, with net buying
turnover of HK$1.26m, falling a combined 15.6% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
SKB BIO-B (06990) 144.80 -9.84
HUTCHMED (00013) 26.75 +0.75
GENSCRIPT BIO (01548) 14.34 -0.97
INNOVENT BIO (01801) 38.10 -1.17
EVEREST MED-B (01952) 22.30 +3.48
SIRNAOMICS-B (02257) 9.52 +7.21
WUXI XDC (02268) 17.18 +3.37
WUXI BIO (02269) 13.78 +1.62
TIGERMED (03347) 28.85 +1.58
AKESO (09926) 45.95 -2.13
---------------------------------------------
(ed)